Sequana Medical Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Sequana Medical's earnings have been declining at an average annual rate of -15.8%, while the Medical Equipment industry saw earnings growing at 9.6% annually. Revenues have been declining at an average rate of 10% per year.
Belangrijke informatie
-15.8%
Groei van de winst
2.9%
Groei van de winst per aandeel
| Medical Equipment Groei van de industrie | 12.3% |
| Inkomstengroei | -10.0% |
| Rendement op eigen vermogen | n/a |
| Nettomarge | -6,269.8% |
| Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Opbrengsten en kosten
Hoe Sequana Medical geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
| Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
|---|---|---|---|---|
| 30 Jun 24 | 0 | -27 | 21 | 3 |
| 31 Mar 24 | 1 | -30 | 24 | 3 |
| 31 Dec 23 | 1 | -33 | 26 | 4 |
| 30 Sep 23 | 1 | -32 | 27 | 4 |
| 30 Jun 23 | 1 | -32 | 27 | 4 |
| 31 Mar 23 | 1 | -32 | 26 | 4 |
| 31 Dec 22 | 1 | -31 | 25 | 4 |
| 30 Sep 22 | 1 | -29 | 24 | 4 |
| 30 Jun 22 | 1 | -27 | 23 | 3 |
| 31 Mar 22 | 1 | -25 | 22 | 3 |
| 31 Dec 21 | 0 | -24 | 21 | 3 |
| 30 Sep 21 | 0 | -23 | 19 | 3 |
| 30 Jun 21 | 0 | -21 | 18 | 3 |
| 31 Mar 21 | 1 | -20 | 17 | 2 |
| 31 Dec 20 | 1 | -19 | 17 | 2 |
| 30 Sep 20 | 1 | -18 | 16 | 2 |
| 30 Jun 20 | 1 | -17 | 16 | 1 |
| 31 Mar 20 | 1 | -16 | 15 | 1 |
| 31 Dec 19 | 1 | -15 | 14 | 1 |
| 30 Sep 19 | 1 | -16 | 12 | 2 |
| 30 Jun 19 | 1 | -16 | 12 | 2 |
| 31 Mar 19 | 1 | -15 | 11 | 2 |
| 31 Dec 18 | 1 | -14 | 10 | 2 |
| 30 Sep 18 | 1 | -10 | 9 | 1 |
| 31 Dec 17 | 1 | -8 | 8 | 1 |
| 31 Dec 16 | 1 | -14 | 14 | 1 |
| 31 Dec 15 | 2 | -12 | 12 | 1 |
Kwaliteitswinsten: SEQUA is currently unprofitable.
Groeiende winstmarge: SEQUA is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: SEQUA is unprofitable, and losses have increased over the past 5 years at a rate of 15.8% per year.
Versnelling van de groei: Unable to compare SEQUA's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: SEQUA is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.7%).
Rendement op eigen vermogen
Hoge ROE: SEQUA's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.